FAQs on Smoldering Multiple Myeloma: Understanding and Managing your Diagnosis
Chris Peña, Director of Education Programs at the Multiple Myeloma Research Foundation, gets answers to frequently asked questions on smoldering multiple myeloma (SMM) from Dr. Ola Landgren (Professor of Medicine and Chief, Division of Myeloma & Myeloma Institute, University of Miami in Florida); Kelly Koubek (APRN Supervisor, Research Nurse Practitioner, Sylvester Myeloma Institute); and Jennifer Stone, an SMM patient. Dr. Landgren, Ms. Koubek, and Ms. Stone provide insights on smoldering myeloma, including... 00:40 General 22:58 Monitoring and Treatment of SMM This session is supported by Adaptive, Amgen, Bristol Myers Squibb, CURE, Genentech, Kite/Arcellx, and Pfizer. If you have questions, call our MMRF Patient Navigation Center at 1-888-841-6673.

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action

FAQs on Understanding Your Test Results

I Have To Wait To Get CANCER TREATMENT! - Brad | High Risk Smoldering Myeloma | The Patient Story

FAQs on Myeloma Updates from ASCO & EHA 2025

Newly Diagnosed with Multiple Myeloma? How to Navigate Your First Steps.

How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar

My Multiple Myeloma Diagnosis: "They Weren't the Typical Symptoms" | Julie's Story

FAQs: Understanding Your Test Results: Key Insights for Multiple Myeloma Patients

Treating Complex Spine Disorders: State of the Art Solutions

Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Plasma Cell Disorders | Clinical Medicine

Is Multiple Myeloma Fatal? What Experts Say About Living a Normal Life

Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk

Understanding MGUS, Its Progression Risks, and More

How Stress and Bone Clicks Revealed My Cancer! - Yolanda | Multiple Myeloma | The Patient Story

FAQs: Understanding High-Risk Multiple Myeloma: Beyond Genetics and Key Considerations

Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines

